Case Report: Cardiac metastasis from urothelial carcinoma with predominant squamous differentiation in a young woman: first reported case treated with enfortumab vedotin plus pembrolizumab - Takeaways - MDSpire

Case Report: Cardiac metastasis from urothelial carcinoma with predominant squamous differentiation in a young woman: first reported case treated with enfortumab vedotin plus pembrolizumab

  • By

  • Alix Vansteeger

  • El Mamoune El Ghali Benlemlih

  • Antoine Delmarche

  • Stéphane Thiry

  • Hélène Dano

  • Justine Castaigne

  • Vassiliki Pasoglou

  • Sandy Van Nieuwenhove

  • Bernhard Gerber

  • Gaby Aphram

  • Qaid Ahmed Shagera

  • Christophe Beauloye

  • Rachel Galot

  • Cédric van Marcke

  • Emmanuel Seront

  • May 20, 2026

  • 0 min

Share

  • 1

    Cardiac metastases from urothelial carcinoma are rare and associated with poor prognosis, particularly in young patients.

  • 2

    A 36-year-old woman with muscle-invasive bladder cancer presented with a large right ventricular mass requiring urgent surgical intervention.

  • 3

    The cardiac lesion exhibited a pure squamous phenotype, indicating aggressive tumor biology and a potential clonal selection.

  • 4

    Postoperative treatment with enfortumab vedotin and pembrolizumab was initiated, but the patient experienced rapid deterioration.

  • 5

    This case highlights the challenges of managing squamous-dominant metastatic urothelial carcinoma with cardiac involvement.

Original Source(s)

Related Content